Complications After Corneal Allografts Intrastromal Rings Segments (CAIRS) In Keratoconus And Post LASIK Ectasia A Case Series

Why It Matters

These findings expose safety gaps in a promising keratoconus therapy, influencing surgical practice and regulatory oversight.

Key Takeaways

• Nine CAIRS cases showed corneal neovascularization and extrusion
• Excessive thinning and shallow tunnels increased complication risk
• Topical steroids and explantation were primary management strategies
• Early detection essential to prevent lipid deposition and vision loss
• Standardized guidelines needed for CAIRS implantation and follow‑up

Pulse Analysis

The corneal allogenic intracorneal ring segment (CAIRS) has emerged as a biologic alternative to synthetic intrastromal rings for correcting irregular astigmatism in keratoconus and post‑LASIK ectasia. By using donor tissue, CAIRS promises improved biocompatibility and reduced foreign‑body reaction, while delivering comparable flattening of the corneal apex. However, the technique remains relatively niche, with only a handful of complications reported in the literature. This multicenter case series, encompassing nine eyes across three countries, provides the largest systematic look at adverse events, shedding light on safety considerations that were previously anecdotal.

The series identified three principal complications: progressive corneal neovascularization encroaching on the CAIRS tunnel, lipoid keratopathy from chronic vascular leakage, and segment extrusion. Common pre‑operative risk factors included marked corneal thinning and overly superficial tunnel creation, which likely facilitated vascular ingrowth and mechanical instability. Post‑operative lapses in monitoring further allowed inflammation to advance unchecked. Management combined aggressive topical corticosteroids to curb neovascularization with surgical interventions—segment trimming or explantation—when structural compromise persisted. Outcomes improved when therapy was initiated promptly, underscoring the value of vigilant follow‑up.

From a business and clinical perspective, these findings highlight the necessity for standardized implantation protocols and postoperative surveillance pathways. Eye‑care providers must refine patient‑selection criteria, ensuring adequate stromal thickness and employing precise femtosecond‑laser tunnel depth settings. Moreover, the data support the development of training modules and registries to track long‑term safety, which could accelerate regulatory acceptance and market adoption of CAIRS. As the demand for minimally invasive keratoconus solutions grows, aligning surgical technique with evidence‑based guidelines will be pivotal in preserving visual outcomes and sustaining confidence among surgeons and patients alike.